About: Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 19 July 2007

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 2007 (uk) article scientifique publié en 2007 (fr) im Juli 2007 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 19 July 2007 (en) artículu científicu espublizáu en xunetu de 2007 (ast)
publication date	wds:Q57750563-F5A484C8-4451-4D91-A73C-372C0342979C
publication date	2007-07-19 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57750563-5C2786FB-7E28-474E-8FCF-2BE81A836E17
language of work or name	English
cites work	wds:Q57750563-0A19197F-5491-4310-8FC3-5B6956AF7B0C wds:Q57750563-2D66CEE7-5C6D-4E2D-A266-C6625B1FB218 wds:Q57750563-3914DF9A-BAC2-4ED1-BBC0-89C2D93BAEDA wds:Q57750563-3AC76CE0-F077-47F4-9222-7EC00246BBB2 wds:Q57750563-3C26ED97-B622-4E6F-B44C-6769DC6136B8 wds:Q57750563-3C656135-A623-4511-8887-6A4139C18168 wds:Q57750563-5557D701-0D15-4A68-A7DB-07257FBD298E wds:Q57750563-726E2955-EB75-4DD3-9491-08F486C244DA wds:Q57750563-79C9EE6E-6818-4393-89D8-C45C1616549C wds:Q57750563-8154B6B6-D8BE-4533-9276-145163E51236 wds:Q57750563-A302BCCD-02F8-413F-B10D-5779543A2A67 wds:Q57750563-A6565612-C46C-4762-9FC5-F9E249AA4CB8 wds:Q57750563-B36EC21C-DA24-453D-8B43-6059A83C460B wds:Q57750563-E92A4398-BF0A-4F1F-B6F4-607D402119E4 wds:Q57750563-FA242B44-3B50-4BE5-BEDD-D51F99D24190 wds:Q57750563-FDA406BA-830A-4123-9B0B-FF13D20CC3C2
cites work	A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. Valganciclovir: a review of its use in the management of CMV infection and disease in immunocompromised patients The interplay between host and viral factors in shaping the outcome of cytomegalovirus infection Infection in organ-transplant recipients Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients Dynamics of Cytomegalovirus Replication during Preemptive Therapy with Oral Ganciclovir Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients Single-dose pharmacokinetics of valganciclovir in HIV- and CMV-seropositive subjects Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation Oral valganciclovir as pre-emptive therapy has similar efficacy on cytomegalovirus DNA load reduction as intravenous ganciclovir in allogeneic stem cell transplantation recipients. Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir A safety study of oral valganciclovir maintenance treatment of cytomegalovirus retinitis.
author name string	wds:Q57750563-02634C6C-FE81-4BD3-840D-486E58B68DC3 wds:Q57750563-7054BC2C-00EA-450F-AE3C-97548264EB02 wds:Q57750563-72FB2E54-96C5-4D44-B9FD-B17CA3C59BB8 wds:Q57750563-735A796A-CDC2-4F75-905A-B09FF4BC891B wds:Q57750563-7FF4947C-28D0-4C69-AFB4-0CAFFB649BE4 wds:Q57750563-860B1F34-58E2-4481-A4FB-5A72AFB79CE7 wds:Q57750563-95720003-64C1-45E6-9B8B-33FA91A157BC wds:Q57750563-9C42AB7A-6F48-4679-A653-DC6DC30714B0 wds:Q57750563-E7CE3610-C329-4B88-9B12-91E06D37E2B2
author name string	M Tuncer M D Pescovitz A Hartmann H Rollag I L Noronha A Humar A Asberg H Mouas VICTOR Study Group
rdfs:label	Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients (en) Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients (nl)
skos:prefLabel	Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients (en) Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients (nl)
name	Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients (en) Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients (nl)
author	wds:Q57750563-1224C433-10F7-4E44-97C8-CBFF2417CA19 wds:Q57750563-926713F9-F31C-47C2-8B15-F93710501ADA
author	Dino Sgarabotto Alan Jardine
title	wds:Q57750563-B17936B0-9E39-4D2E-9334-63DF69F0AFE4
title	Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients (en)
page(s)	wds:Q57750563-E9F68668-AF91-42C6-8EF3-C51F4DB417FA
page(s)	2106-2113
instance of	wds:Q57750563-35BB7060-32F6-4B02-8753-A3C121E87106
instance of	scholarly article
main subject	wds:Q57750563-AA2410BF-3AE8-43DD-92AF-21EF2CD2A3E9 wds:Q57750563-CC826DE1-F250-469A-AF19-149BCB3E7077
main subject	valganciclovir Cytomegalovirus
PubMed ID	wds:Q57750563-BEA79448-F0F5-47BB-A68B-FE1E717FC346
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17640310
PubMed ID	17640310
published in	wds:Q57750563-9E911DD4-A062-4D9E-A944-E61F8842A0C0
published in	American Journal of Transplantation
issue	wds:Q57750563-080ACEDE-745B-44C0-B3F1-133FED344FF4
volume	wds:Q57750563-2F38D9EF-C7B9-486E-9008-B2322DC58A6D
issue	9
volume	7
DOI	wds:Q57750563-20861787-EF3B-4548-B42B-19B15BC46F3C
DOI	http://dx.doi.org/10.1111/J.1600-6143.2007.01910.X
DOI	10.1111/J.1600-6143.2007.01910.X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57750563
is cites work of	Fatal graft-versus-host disease presenting as fever of unknown origin in a pancreas-after-kidney transplant recipient Homozygosity for the toll-like receptor 2 R753Q single-nucleotide polymorphism is a risk factor for cytomegalovirus disease after liver transplantation Population pharmacokinetics of ganciclovir after intravenous ganciclovir and oral valganciclovir administration in solid organ transplant patients infected with cytomegalovirus. Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis Gastrointestinal cytomegalovirus disease in the immunocompromised patient Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software